« Sundance Watch: Henry Poole and Choke Sell | Main | Sundance Watch: American Teen Still Up for Grabs »

January 22, 2008

Sundance Watch: Hamlet 2 Sells to Focus for $10 Million

Hamlet_art_200_20080122100431_2Sundance's Buyer's Block has broken, as Focus Features has confirmed the acquisition the wee hours Tuesday morning of all world rights to the Steve Coogan comedy Hamlet 2 for $10 million after an intense bidding war. Among the companies vying for the rights were Summit Entertainment, Weinstein Co., Lionsgate, and Warner Independent.

Hamlet 2, a late edition to the Sundance lineup, premiered to raucous laughter at the Library Monday at 5:30 PM. The filmmakers and Coogan repaired to a party at Jean Louis off Main Street, while the buyers converged on the CAA condo, where the agency closed the deal around 3 AM. $10 million is a high figure for Sundance; other sales at that level include Spitfire Grill and Little Miss Sunshine.

Coogan stars as a high school drama teacher who writes a sequel to the Shakespeare tragedy in order to save his drama department. The film also stars Catherine Keener, Amy Poehler and David Arquette.

It was a good day for Focus: they not only nabbed the hottest title at Sundance but scored seven Oscar noms for Atonement, including best picture.

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/t/trackback/4113/25371416

Listed below are links to weblogs that reference Sundance Watch: Hamlet 2 Sells to Focus for $10 Million:

Comments

That Elisabeth Shue is a hottie. I can't wait for this movie to come out... anyone know a release date?

Post a comment

If you have a TypeKey or TypePad account, please Sign In

About

Variety.com deputy editor Anne Thompson writes a weekly Variety film column as well as this daily blog.

Categories

Digg!

Add to Google Reader or Homepage

Subscribe in NewsGator Online

Add to My AOL

Subscribe in Bloglines

Blog Flux Directory

http://www.wikio.com

TIP ANNE THOMPSON



Anne's Links


© 2007 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this web site is subject to its Terms and Conditions of Use. View our Privacy Policy.